C.V Juan C. Alfonso Farto


1       Graduated in Medicine. July 1987. Universidad Complutense. Madrid

2.      Ph D. Dec 1994. Universidad Complutense. Madrid

3.      Associated Professor. July 2000. Hosp. Gral Univ. Gregorio Marañón. Madrid.


Nuclear Medicine Specialist. Head of Nuclear Medicine Service (2 Services)

– Hosp. Gral. Univ. Gregorio Marañón. Servicio de Medicina Nuclear. Consejería de Salud. Comunidad Autónoma de Madrid. C/ Doctor Esquerdo 46, 28007, Madrid

– MD Anderson-ITSS. Gómez Hemans 2-4, planta -1, 28033 Madrid.

START DATE: November 1999


1. Staff Nuclear Medicine Specialist. 1995-1999. Complejo Hospitalario de Ciudad Real

2. Auditor (internal quality control). 2007- Present. HGU Gregorio Marañón

3. Human Research Ethics Committee Member. 2007- 2014. Area 1, Madrid

4. Secretary-President. 2007- 2009. SEMN Cardiology Group.

5. Secretary-General. 2001-2006. Nuclear Medicine Spanish Society

6. Quality responsible. 2005- 2009. N.M. Dept. HGU Gregorio Marañón

7. President of Nuclear Medicine Spanish Society. 2013-2017

8. National Commission for Nuclear Medicine Specialty Member. 2014- Present. Ministry of Health


1.         Kestler M, Munoz P, Rodriguez-Creixems M, Rotger A, Jimenez-Requena F, Mari A, et al. Role of (18)F-FDG PET in Patients with Infectious Endocarditis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2014;55(7):1093-8.

2.         Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, Ibanez B, Lopez-Melgar B, Laclaustra M, et al. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104-

3.         Rodado-Marina S, Coronado-Poggio M, García-Vicente AM, García-Garzón JR, Alonso-Farto JC, de la Jara AC, et al. Clinical utility of 18 F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study: Utility of PET/CT in biochemical relapse of prostate cancer after radical treatment. BJU International. 2015;115(6):874-83.

4.         Alonso Farto JC. Es la hora de la medicina nuclear. Revista espanola de medicina nuclear e imagen molecular. 2016;35(4):213-4.

5.    Mota-Cobian A, Alonso-Farto JC, Fernandez-Friera L, Sanchez-Gonzalez J, Lopez-Melgar B, Jimenez-Borreguero LJ, et al. The effect of tissue-segmented attenuation maps on PET quantification with a special focus on large arteries. Revista espanola de medicina nuclear e imagen molecular. 2018;37(2):94-102.